Clinical Trial Update: Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating white blood cell counts in cerebrospinal fluid and blood of patients with relapsing multiple sclerosis. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: GlaxoSmithKline | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED